Jon M. Foster, Executive Vice President and Chief Operating Officer of HCA Healthcare, Inc. (NYSE:HCA), filed a Form 4 on November 6, 2026, disclosing a series of common stock transactions dated November 4 and November 6, 2026.
Mary K. Moreland, Executive Vice President of Abbott Laboratories, filed a Form 4 on November 6, 2026, disclosing a sale of common shares on November 5, 2026.
Saba Capital Management, L.P. filed a Form 4 on November 6, 2026, disclosing a purchase of common stock in Japan Smaller Capitalization Fund Inc (NYSE:JOF) on November 5, 2026.
Director Ronald J. Pasek filed a Form 4 with the SEC on November 6, 2026, disclosing restricted stock unit transactions at Extreme Networks Inc. (NASDAQ:EXTR) dated November 4, 2026.
Michael J. Schlosser, EVP and Chief Clinical Officer of HCA Healthcare, Inc., filed a Form 4 on November 6, 2026, disclosing the sale of 1,200 shares of HCA Healthcare common stock on November 4, 2026.
Director Edward H. Kennedy filed a Form 4 with the SEC on November 6, 2026, reporting the vesting of 11,767 restricted stock units and the award of 9,413 new restricted stock units in Extreme Networks Inc. (NASDAQ:EXTR) on November 4, 2026.
Director Kathleen M. Holmgren filed a Form 4 with the SEC on November 6, 2026, disclosing the vesting of 11,767 restricted stock units and the grant of 9,413 new restricted stock units in Extreme Networks Inc. (NASDAQ:EXTR) on November 4, 2026.
Director Raj Khanna filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 11,767 shares of Extreme Networks common stock through the vesting of restricted stock units on November 4, 2026.
Chris J. Robertson, Controller at Agilysys, Inc., filed a statement of changes in beneficial ownership on November 6, 2026, disclosing the acquisition of 922 restricted stock units on November 4, 2026.
Director John C. Shoemaker filed a Form 4 with the SEC on November 6, 2026, reporting the vesting of 11,767 restricted stock units and the grant of 9,413 new restricted stock units in Extreme Networks Inc. (NASDAQ:EXTR) on November 4, 2026.